<DOC>
	<DOCNO>NCT00671515</DOCNO>
	<brief_summary>The goal study begin test whether pioglitazone , FDA approve medication use treat high blood sugar , may safe effective treat Major Depressive Disorder ( MDD ) patient comorbid Metabolic Syndrome ( METSYN ) .</brief_summary>
	<brief_title>Pioglitazone Treatment Major Depressive Disorder Comorbid With Metabolic Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<criteria>Be male female age 18 70 DSMIV diagnosis major depressive disorder Currently depress confirm MINIPlus screen visit Quick Inventory Depressive SymptomatologySelfReport ( QIDSSR ) score &gt; 11 study baseline Meets criteria metabolic syndrome define NCEP ATP III criterion Pregnancy breast feed Unstable inadequately treat medical illness judge investigator Severe personality disorder Serious suicidal risk judge investigator score &gt; 2 item 18 Inventory Depressive SymptomatologyClinician Rated ( IDSCR ) scale Known history intolerance hypersensitivity pioglitazone Treatment pioglitazone 3 month prior randomization Currently take antidiabetic/glucoselowering agent . Antidiabetic agent prohibit include insulin , rosiglitazone , metformin , sitagliptin , sulfonylurea ( e.g . glyburide , glipizide , glimepiride ) , nonsulfonylurea secretagogues ( e.g . repaglinide , nateglinide ) , incretins ( e.g . exenatide ) , Î±glucosidase inhibitor ( e.g . acarbose , miglitol ) . Diagnosed dementia Diagnosed heart failure Transaminase elevation &gt; 2.5 time upper limit normal Presence renal impairment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Depressive Disorder , Major</keyword>
	<keyword>Metabolic Syndrome X</keyword>
	<keyword>pioglitazone</keyword>
</DOC>